Clinical trial Recruiting at 1 site Interventional Ages 18 to 64 Women only

Time-restricted feeding for immune health in people with severe obesity

Official title: Exploring the Effects of Time-Restricted Feeding on the Immune Function of Obese Individuals: A Multi-Omic Approach

Run by Hospital Universitari Vall d'Hebron Research Institute · NCT06858683 · Data updated 2026-11-12

This trial will test whether eating only during an 8-hour window improves immune function in adults with severe obesity who are preparing for bariatric surgery.

More Obesity and Obesity-related Medical Conditions trials

Quick facts

Study typeInterventional
Ages18 Years to 64 Years
SexWomen only
Enrollment45 (estimated)
SponsorHospital Universitari Vall d'Hebron Research Institute
Academic / other
Locations1 site (Barcelona)
StatusRecruiting
StartedMarch 21, 2025
Main results expectedDecember 31, 2026
Study endsDecember 31, 2026
Registry record updatedJune 8, 2025
Trial IDNCT06858683 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18–64 with BMI 40–50 kg/m² who are scheduled for bariatric surgery in about 10–12 weeks, have had stable weight and a three-meal pattern, and can speak Catalan or Spanish and attend Vall d'Hebron in Barcelona.

Probably not a fit

People with type 1 or type 2 diabetes, major cardiovascular disease, current pregnancy, recent cancer, use of immunosuppressive or interfering medications, night-shift workers, or those who cannot follow the language or location requirements are unlikely to benefit or are ineligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Adults with obesity (BMI 40–50 kg/m²) scheduled for bariatric surgery will be randomized to follow time-restricted feeding (8-hour eating window) or a standard longer eating window for about 10–12 weeks before surgery. Researchers will collect blood and tissue samples and use multi-omics techniques to profile immune cells and how white fat cells respond to the diet change. The trial compares immune function and molecular signatures between the two groups to identify mechanisms linking feeding time to immune competence. Outcomes aim to define whether TRF can restore immune responses impaired in severe obesity and how adipocytes contribute to those changes.

Why it matters

Potential benefit: If successful, the intervention could improve immune function and reduce immune-related complications around bariatric surgery for people with severe obesity.

How similar studies have gone: Previous time-restricted feeding studies have shown metabolic benefits, but using TRF specifically to modify immune function and adipocyte immunomodulation is relatively novel and less well established.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Patients with obesity

* Women
* Age 18-64 years
* Body mass Index between 40-50 kg/m²
* Scheduled bariatric surgery 10-12 weeks after the nutritional intervention
* Self-reported eating pattern window of more than 14h
* Three meal eating pattern
* Stable body weight (less than 10% of current body weight during the last 3 months)
* Patients who have a favorable decision from the multidisciplinary team meetings after multidisciplinary nutritional follow-up of at least 6 months and history of failure with non-surgical weight loss methods
* Social security affiliation
* Written consent
* Good understanding of the Catalan or Spanish languages

Exclusion Criteria:

* Diabetes type I or II
* Major cardiovascular disease
* Pregnancy
* Medication that could affect the study outcomes (i.e. anti-inflammatory drugs, antibiotics, immunosuppressors)
* Use products intended for weight loss
* Night work shift
* Past record of malignant tumors
* Serious liver dysfunction or chronic kidney disease
* Eating disorders
* Chronic viral disease (Hepatitis B or C, HIV) or inflammatory systemic diseases (i.e. Crohn's disease, rheumatoid arthritis)
* Serious cardiovascular or cerebrovascular disease within 6 months before randomization
* Severe gastrointestinal diseases or gastrointestinal surgery in the 12 months before randomization
* Under guardianship, curatorship, deprived of liberty
* Unable or unwilling to sign the informed consent form.

Where it's running

  • Vall Hebron Barcelona Hospital Campus
    Barcelona, Spain
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.